Search
for
Sort by
Research 91–120 of 1000+
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Oral Manifestations of Hematologic and Nutritional Diseases
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Dermatolojik Problemler ve COVID-19
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Abstracts
- The pathogenesis of alopecia areata
- The Skin and Subcutaneous Tissues
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Gut microbiota in alopecia areata
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Complications in Esthetic Surgery
- Atlas of Geriatric Dermatology
- Lupus erythematosus: systemic and cutaneous manifestations
- What causes hidradenitis suppurativa ?—15 years after
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Diagnosis and Management of Alopecia in Children
- Alopecia Areata. Current situation and perspectives
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Cutaneous Lupus Erythematosus
- Group IID, IIE, IIF and III secreted phospholipase A2s
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Multiple Autoimmune Syndrome With Alopecia Universalis and Immune Thrombocytopenic Purpura